Rdot is collaborating with a US actor to develop new medical technology. The project involves the development of ultra-thin, flexible, biocompatible, and transparent electrochromic devices. Further details are unavailable in accordance with an NDA.
The 4-month research and development project was successfully delivered in April 2019. The undisclosed client is a US-based medical technology actor that is developing cutting-edge technology with immense market potential. Project details are still under NDA but can be summarized as follows:
Transparent electrochromic display (wide range of light transmission depending on on/off state)